ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,029Medicare Part D Prescriptions Filled, Including Refills

Rank: 276 out of 1499

$551K Total Retail Price of All Prescriptions

Rank: 276 out of 1499

671 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 671 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 671 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,925 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 636 357 S3 1 4
LISINOPRIL 375 283 2 1
LEVOTHYROXINE SODIUM 346 228 3 2
HYDROCHLOROTHIAZIDE 308 234 4 9
OMEPRAZOLE 304 195 5 5
ATENOLOL 273 183 6 21
AMLODIPINE BESYLATE 268 238 7 6
METFORMIN HCL 265 157 8 8
LOVASTATIN 207 160 9 19
RANITIDINE HCL 207 113 9 15
GABAPENTIN 202 122 11 13
FUROSEMIDE 180 160 12 7
SINGULAIR 160 83 13 67
POTASSIUM CHLORIDE 142 111 14 11
TRAMADOL HCL 140 81 15 16
ATORVASTATIN CALCIUM 138 96 16 17
METOPROLOL TARTRATE 132 87 17 10
ZOLPIDEM TARTRATE 130 88 18 23
AZITHROMYCIN 124 75 19 45
IBUPROFEN 122 57 20 70
FLUTICASONE PROPIONATE 120 82 21 31
CITALOPRAM HBR 115 45 22 14
SIMVASTATIN 110 71 23 3
WARFARIN SODIUM 110 73 23 12
GLIPIZIDE XL 103 89 25 164
SERTRALINE HCL 102 74 26 24
SPIRIVA 96 64 27 44
PROAIR HFA 93 40 28 30
CARBAMAZEPINE 90 13 29 184
MONTELUKAST SODIUM 81 42 30 133
SPIRONOLACTONE 81 78 30 61
ADVAIR DISKUS 80 63 32 37
OXYCODONE-ACETAMINOPHEN 74 37 S2 33 80
GLIPIZIDE ER 69 60 34 129
LOSARTAN POTASSIUM 68 52 35 26
PRAVASTATIN SODIUM 67 42 36 18
FLUOXETINE HCL 67 11 36 43
METHADONE HCL 65 13 S2 38 170
PROMETHAZINE HCL 65 13 R 38 138
TERAZOSIN HCL 65 61 38 147
JANUVIA 63 46 41 84
CARISOPRODOL 62 13 R 42 71
GEMFIBROZIL 60 23 43 88
MELOXICAM 58 33 44 27
TOPIRAMATE 58 12 44 128
CLOPIDOGREL 58 29 44 39
PRENATAL PLUS 58 24 44 157
ALLOPURINOL 54 50 48 36
NAPROXEN 54 20 48 63
LANTUS 54 25 48 46
LIPITOR 52 14 51 107
PLAVIX 52 36 51 54
PANTOPRAZOLE SODIUM 52 42 51 48
AMITRIPTYLINE HCL 51 25 R 54 49
ACTOS 51 47 54 145
ALENDRONATE SODIUM 50 50 56 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.